149 related articles for article (PubMed ID: 9070705)
21. Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions.
Christiansen OB; Christiansen BS; Husth M; Mathiesen O; Lauritsen JG; Grunnet N
Fertil Steril; 1992 Aug; 58(2):328-34. PubMed ID: 1633897
[TBL] [Abstract][Full Text] [Related]
22. Intravenous immunoglobulin in women with five or more abortions.
Carp HJ; Ahiron R; Mashiach S; Schonfeld Y; Gazit E; Toder V
Am J Reprod Immunol; 1996 Apr; 35(4):360-2. PubMed ID: 8739454
[TBL] [Abstract][Full Text] [Related]
23. Placebo-controlled trial of active immunization with third party leukocytes in recurrent miscarriage.
Christiansen OB; Mathiesen O; Husth M; Lauritsen JG; Grunnet N
Acta Obstet Gynecol Scand; 1994 Mar; 73(3):261-8. PubMed ID: 8122510
[TBL] [Abstract][Full Text] [Related]
24. Recurrent spontaneous abortion: histocompatibility between partners, response to immune therapy, and subsequent reproductive performance.
van Iddekinge B; Hofmeyr GJ; Bezwoda WR; Wadee AA; Van Rooy P
Am J Reprod Immunol; 1993 Aug; 30(1):37-44. PubMed ID: 8260022
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of immunotherapy in early pregnancy with x-irradiated paternal mononuclear cells for primary recurrent aborters.
Aoki K; Kajiura S; Matsumoto Y; Yagami Y
Am J Obstet Gynecol; 1993 Sep; 169(3):649-53. PubMed ID: 8372875
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy for recurrent miscarriage.
Wong LF; Porter TF; Scott JR
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD000112. PubMed ID: 25331518
[TBL] [Abstract][Full Text] [Related]
27. The effect of serum follicular phase luteinizing hormone concentrations in habitual abortion: correlation with results of paternal leukocyte immunization.
Carp HJ; Hass Y; Dolicky M; Goldenberg M; Mashiach S; Rabinovici J
Hum Reprod; 1995 Jul; 10(7):1702-5. PubMed ID: 8582964
[TBL] [Abstract][Full Text] [Related]
28. Immunologic testing and immunotherapy in recurrent spontaneous abortion.
McIntyre JA; Faulk WP; Nichols-Johnson VR; Taylor CG
Obstet Gynecol; 1986 Feb; 67(2):169-75. PubMed ID: 2935759
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy for recurrent miscarriage.
Scott JR
Cochrane Database Syst Rev; 2003; (1):CD000112. PubMed ID: 12535385
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials.
Coulam CB; Stephenson M; Stern JJ; Clark DA
Am J Reprod Immunol; 1996 Apr; 35(4):352-9. PubMed ID: 8739453
[TBL] [Abstract][Full Text] [Related]
31. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia.
Carp H; Dolitzky M; Inbal A
J Thromb Haemost; 2003 Mar; 1(3):433-8. PubMed ID: 12871446
[TBL] [Abstract][Full Text] [Related]
32. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
33. Anti-paternal antibodies by flow cytometry in the management of alloimmunization on recurrent miscarriages.
Matsubayashi H; Maruyama T; Ozawa N; Izumi SI; Sugi T; Yoshikata K; Yoshimura Y; Makino T
Am J Reprod Immunol; 2000 Nov; 44(5):284-8. PubMed ID: 11125790
[TBL] [Abstract][Full Text] [Related]
34. Predictors of pregnancy success in repeated miscarriage.
Cauchi MN; Pepperell R; Kloss M; Lim D
Am J Reprod Immunol; 1991 Sep; 26(2):72-5. PubMed ID: 1768321
[TBL] [Abstract][Full Text] [Related]
35. Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis.
Carp HJ; Toder V; Gazit E; Ahiron R; Torchinski A; Mashiach S; Shoenfeld Y
Am J Reprod Immunol; 2001 Oct; 46(4):268-73. PubMed ID: 11642675
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapy for recurrent pregnancy loss.
Carp H
Best Pract Res Clin Obstet Gynaecol; 2019 Oct; 60():77-86. PubMed ID: 31521575
[TBL] [Abstract][Full Text] [Related]
37. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy outcome in recurrent miscarriage patients with skewed X chromosome inactivation.
Sullivan AE; Lewis T; Stephenson M; Odem R; Schreiber J; Ober C; Branch DW
Obstet Gynecol; 2003 Jun; 101(6):1236-42. PubMed ID: 12798530
[TBL] [Abstract][Full Text] [Related]
39. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth.
Nielsen HS; Witvliet MD; Steffensen R; Haasnoot GW; Goulmy E; Christiansen OB; Claas F
J Reprod Immunol; 2010 Dec; 87(1-2):67-73. PubMed ID: 20605049
[TBL] [Abstract][Full Text] [Related]
40. A practical approach to the prevention of miscarriage: part 2--active immunotherapy.
Check JH
Clin Exp Obstet Gynecol; 2010; 37(1):5-9. PubMed ID: 20420268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
